Our vision is shared with that of PARI GmbH, that is, to improve the lives of those affected by respiratory diseases, such as Cystic Fibrosis, bronchiectasis, etc, and the quality of life of those who care for them.
Our focus is on marketing a portfolio of world renowned products for comprehensive management of cystic fibrosis, bronchiectasis & chronic respiratory diseases.
Our product range includes a range of leading products including the innovative Pari® GmbH aerosol medication delivery and airway clearance products, Spiro PD Personal Spirometers, pharmaceuticals for cystic fibrosis and Pancreatic deficiency, such as Panzytrat ® (pancreatic enzymes) & VitABDECK ® water solubilised vitamins.
PARI’s MucoClear® hypertonic saline solution for inhalation, is TGA approved and is available for purchase around Australia. MucoClear® is available in two strengths (3% and 6%) in specially formulated 4 ml plastic ampoules which are easy to use, sterile and mobile.
Further information on MucoClear® Hypertonic Saline is available on our product page.
Through continued support of Cystic Fibrosis Allied Health professionals, Technipro-PulmoMed has funded Fellowships since 2000.
The fellowships are specifically for nurses, physiotherapists, dietitians and other allied health people working in Cystic Fibrosis. Applications are sent to Cystic Fibrosis Australia who have a panel choosing the winners.
The aim of the fellowship is to improve the knowledge and skills of Allied Health Professionals working in Cystic Fibrosis for research and/or travel to leading overseas conferences so as to enhance their knowledge for the improvement in quality of life for people affected by Cystic Fibrosis in Australia.
We renamed the scholarships in memory of Abbie Fennessy who lost her battle with Cystic Fibrosis in 2012. Abbie joined Technipro-PulmoMed in late 2010, while in her last year at university studying health science. Abbie worked with Technipro-PulmoMed for a few years, and inspired every one of her colleagues. We wanted to acknowledge her spirited contribution to Cystic Fibrosis by naming the fellowships after her.
The Cystic Fibrosis Australia (CFA) initiative is sponsored by Technipro-PulmoMed. For further information on how to apply for the scholarships, please visit the Cystic Fibrosis Australia Website.
Abbie’s family have set up a trust fund in conjunction with Cystic Fibrosis Victoria to honour Abbie’s life and encourage other young adults suffering with Cystic Fibrosis. Their aim is to raise money to support these amazing individuals who are fighting this debilitating illness every day. To donate to the Abbie Fennessy Trust, please visit Abbie’s Trust Page.
We are proud to announce that in 2012 we introduced Spiro PD – the worlds first personal spirometer, allowing you to monitor your spirometry accurately and comprehensively, anywhere.
Spiro PD can track your lung function trends and alert you of a decline in lung function before you begin to feel symptoms. This helps you anticipate and prevent exacerbations and asthma attacks, and reduce expensive emergency room visits and hospital stays.
Spiro PD enhances medication adherence by enabling you to manage your medications, view your medication history, and set alarms reminding you when to take your medicine, test your lung function, and do breathing exercises. You can also quickly upload lung function data to share with your doctor by simply attaching the results to an email.